Subjects will be selected from groups known to be at high risk for heart disease, to make sure that enough adverse events occur to be able to get a good read on which drug causes the most.Dr. Nissen's take on this according to L&B: there remains a valid open question as to which drug is the lowest risk and so should be preferred in practice.